Study on Treatment of Varicose Veins by Endovenous Laser (1940 nm vs 1470 nm)

Study Overview
=================
Brief Summary
-----------------
The goal of this clinical trial is to compare efficacy of two wavelength for EndoVenous Laser Ablation (EVLA) in treatment of varicose veins of the lower limbs. The main questions it aims to answers are : Is the increase of wavelength form 1470 nm to 1940 nm affect the efficacy of varicose veins treatment ? Is the increase of wavelength reduce complication or pain ? Participants are patients with varicose veins of lower limbs and candidate for endovenous laser ablation. After laser ablation patients will be followed during 5 years for clinical evaluation, recording potential treatment complications and quality of life evaluation. Researchers will compare strategy 1(EVLA with an endovenous laser at 1940 nm) vs strategy 2 (EVLA with an endovenous laser at 1470 nm) in varicose veins treatment to see if efficacy of treatment is not reduce, and to see if complications of EVLA treatment can be reduced.

Official Title
-----------------
Randomized Comparative Study With Two Wavelengths 1470 nm and 1940 nm for the Treatment of Varicose Veins of the Lower Limbs by Endovenous Laser.

Conditions
-----------------
Varicose Veins

Intervention / Treatment
-----------------
* Procedure: EVLA 1940 nm
* Procedure: EVLA 1470 nm


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Primary insufficiency of the great saphenous vein (GSV) and/or small saphenous vein (SSV) Patient candidate for endothermic treatment of the lower limbs CEAP: C2 - C6 Patient with a target vein diameter (GSV and/or SSV) >= 3 mm throughout the target vein segment Patient affiliated or beneficiary of a social security scheme Patient having signed the informed consent Exclusion Criteria: Patient with a current serious pathology and/or a life expectancy of less than 5 years Patient who has had a deep or superficial vein thrombosis in the previous 6 months Obliterating arteriopathy of the lower limb concerned, with an IPS < 0.8 or > 1.3 Patient with post-thrombotic obstructive syndrome at the popliteal and/or femoral and/or iliac stage on the ipsilateral lower limb Patient with primary or post-thrombotic axial deep venous reflux on the ipsilateral lower limb Suspicion of non-post-thrombotic iliac compression on echo-doppler Contraindication to the planned treatment technique Patient whose geographical distance is not compatible with the follow-up of the study Pregnant or breastfeeding women Patient linguistically or psychologically unable to understand the information given, to give informed consent or to answer the study questionnaires. Protected patients: Adults under guardianship, or other legal protection; Hospitalized without consent.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: 1940 nm<br>Endovenous laser at 1940 nm | Procedure: EVLA 1940 nm<br>* Treatment of varicose veins by endothermic ablation with an endovenous laser at 1940 nm<br>|
| Active Comparator: 1470 nm<br>Endovenous laser at 1470 nm | Procedure: EVLA 1470 nm<br>* Treatment of varicose veins by endothermic ablation with an endovenous laser at 1470 nm<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Anatomical success | Closure of the target vein | At 5 years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| VAS Pain | Visual Analogue Scale (0-100 mm); higher is worse | Day 0, Day 8, Month 6, Year 1, Year 2, Year 3, Year 4, Year 5 | 
| Adverse Events | Adverse events related to endovenous treatment | Day 0, Day 8, Month 6, Year 1, Year 2, Year 3, Year 4, Year 5 | 
| Venous Clinical Severity | Venous Clinical Severity Score (VCSS) ; score between 0 to 30; higher is worse | Day 0, Day 8, Month 6, Year 1, Year 2, Year 3, Year 4, Year 5 | 
| Symptoms | VEINES Sym (VEnous INsufficiency Epidemiologic and Economic Study - Symptoms) questionnaire | Day 0, Month 6, Year 1, Year 2, Year 3, Year 4, Year 5 | 
| Patient quality of life (1) | VEINES Sym (VEnous INsufficiency Epidemiologic and Economic Study - quality of life ) questionnaire | Day 0, Month 6, Year 1, Year 2, Year 3, Year 4, Year 5 | 
| Patient quality of life (2) | EuroQol-5 Dimension (EQ5D) Quality of life survey | Day 0, Month 6, Year 1, Year 2, Year 3, Year 4, Year 5 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Endovenous laser ablation (EVLA)